We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
-3.71%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.59%
AUM
$797M
AUM Growth
-$50M
Cap. Flow
-$11M
Cap. Flow %
-1.38%
Top 10 Hldgs %
35.2%
Holding
175
New
5
Increased
39
Reduced
64
Closed
7

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$1.42M
2
CVX icon
Chevron
CVX
+$817K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$737K
4
HRMY icon
Harmony Biosciences
HRMY
+$408K
5
FLS icon
Flowserve
FLS
+$313K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.8M
2
CVS icon
CVS Health
CVS
+$2.35M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.46M
4
NVDA icon
NVIDIA
NVDA
+$1.21M
5
PDCE
PDC Energy, Inc.
PDCE
+$1.07M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Healthcare 19.84%
3 Consumer Discretionary 9.26%
4 Industrials 7.51%
5 Consumer Staples 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGND icon
76
Ligand Pharmaceuticals
LGND
$6.36B
$2.05M 0.26%
34,160
-12,635
-27% -$832K
ENB icon
77
Enbridge
ENB
$112B
$2.02M 0.25%
60,975
-1,273
-2% -$45.2K
GE icon
78
GE Aerospace
GE
$384B
$1.98M 0.25%
22,434
-233
-1% -$20.9K
DXCM icon
79
DexCom
DXCM
$32B
$1.94M 0.24%
20,786
+12,616
+154% +$1.42M
GNRC icon
80
Generac Holdings
GNRC
$12.5B
$1.89M 0.24%
17,367
+2,065
+13% +$255K
KMB icon
81
Kimberly-Clark
KMB
$36.5B
$1.69M 0.21%
13,984
-955
-6% -$123K
CL icon
82
Colgate-Palmolive
CL
$74.4B
$1.65M 0.21%
23,242
-630
-3% -$47.1K
HDV
83
iShares Core High Dividend ETF
HDV
$14.8B
$1.6M 0.2%
80,900
– –
GD icon
84
General Dynamics
GD
$106B
$1.57M 0.2%
7,106
-178
-2% -$39.4K
VRTX icon
85
Vertex Pharmaceuticals
VRTX
$126B
$1.45M 0.18%
4,177
– –
LNC icon
86
Lincoln National
LNC
$8.81B
$1.45M 0.18%
58,654
+1,079
+2% +$28.2K
CARR icon
87
Carrier Global
CARR
$52.8B
$1.4M 0.18%
25,302
-1,069
-4% -$58.8K
SHW icon
88
Sherwin-Williams
SHW
$89.8B
$1.36M 0.17%
5,346
+280
+6% +$75K
IJR icon
89
iShares Core S&P Small-Cap ETF
IJR
$112B
$1.31M 0.16%
13,837
+925
+7% +$92.4K
SLB icon
90
SLB Ltd
SLB
$75B
$1.3M 0.16%
22,291
-1,055
-5% -$61.2K
BNY
91
Bank of New York Mellon
BNY
$107B
$1.27M 0.16%
29,762
-1,368
-4% -$60.9K
SO icon
92
Southern Company
SO
$107B
$1.17M 0.15%
18,088
-865
-5% -$60K
NBIX icon
93
Neurocrine Biosciences
NBIX
$16.6B
$1.15M 0.14%
10,179
– –
OTIS icon
94
Otis Worldwide
OTIS
$28.2B
$1.1M 0.14%
13,758
-336
-2% -$28.7K
AKAM icon
95
Akamai
AKAM
$15.9B
$1.1M 0.14%
10,295
– –
AXP icon
96
American Express
AXP
$230B
$1.09M 0.14%
7,298
-52
-0.7% -$8.51K
SPGI icon
97
S&P Global
SPGI
$120B
$918K 0.12%
2,513
– –
ALDX icon
98
Aldeyra Therapeutics
ALDX
$93.5M
$916K 0.11%
137,179
– –
D icon
99
Dominion Energy
D
$59.3B
$839K 0.11%
18,774
-550
-3% -$27.3K
CAT icon
100
Caterpillar
CAT
$387B
$814K 0.1%
2,980
-220
-7% -$59.7K
2 3
4
5 6

Similar funds

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

Woodstock Corp's Q3 2023 Portfolio in Review

As of Q3 2023, Woodstock Corp held 175 positions worth $797M, down 5.9% from $847M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Woodstock Corp's Q3 2023 filing shows 5 new, 39 increased, 64 reduced and 7 closed positions. Its largest new stake was Harmony Biosciences: 11,761 shares worth $385K. The largest sale was Bristol-Myers Squibb, an estimated $2.8M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Woodstock Corp's largest Q3 2023 buy was Harmony Biosciences: 11,761 shares worth $385K.
  • Woodstock Corp added most to DexCom in Q3 2023, an estimated $1.42M increase.
  • Woodstock Corp's biggest Q3 2023 reduction was Bristol-Myers Squibb, cutting an estimated $2.8M.
  • Woodstock Corp fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $1.46M.
  • Woodstock Corp's ten largest holdings make up 35% of its $797M portfolio in Q3 2023.
  • Woodstock Corp opened 5 new positions and closed 7 in Q3 2023.
  • Woodstock Corp's portfolio value fell 5.9% quarter-over-quarter to $797M.

Based on Woodstock Corp's 13F filing for Q3 2023, filed 10 Oct 2023.